Join
Live feed
·
INSIDERFilingvia Quantisnow
Zentalis Pharmaceuticals Inc. logo

Chief Legal Officer Paul Andrea was granted 934,041 shares and sold $22,643 worth of shares (13,230 units at $1.71), increasing direct ownership by 614% to 1,070,784 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZNTL (Zentalis Pharmaceuticals Inc.) and more on Quantisnow.